Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Second Primary Malignancies in Patients With Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US

NCT02788409 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02788409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02788409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Second Primary Malignancies in Patients With Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 15, 2016
Completion date
May 9, 2018
Enrollment
2,234 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms